During the past decade, Medizinische Universitaetsklinik I at the University of Cologne conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 17 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Universitaetsklinik I at the University of Cologne" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "German CLL Study Group" with 8 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "University of Minnesota" with 4 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universitaetsklinik I at the University of Cologne" #1 collaborator was "German CLL Study Group" with 4 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Universitaetsklinik I at the University of Cologne" are "Chronic Lymphocytic Leukemia" (11 trials), "Lymphoma" (8 trials), "Rheumatoid Arthritis" (5 trials), "Leukemia" (4 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "Medizinische Universitaetsklinik I at the University of Cologne" in a lesser frequency.

Most popular intervention types in "Medizinische Universitaetsklinik I at the University of Cologne" are "Drug" (52 trials), "Biological" (17 trials), "Procedure" (6 trials), "Radiation" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (10 trials), "doxorubicin hydrochloride" (8 trials), "vincristine sulfate" (7 trials), "Cyclophosphamide" (6 trials) and "Placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Universitaetsklinik I at the University of Cologne" are 56 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medizinische Universitaetsklinik I at the University of Cologne". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Medizinische Universitaetsklinik I at the University of Cologne, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Universitaetsklinik I at the University of Cologne, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".